Matteo Levisetti - 21 Jul 2023 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CUE	Stock Option (right to buy)	Award	$0	+82,500		$0	82,500	21 Jul 2023	Common Stock	82,500	$4.2	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023.